High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
João Lobo(Universidade do Porto), Rui Henrique(Universidade do Porto), Cármen Jerónimo(Universidade do Porto), Luís Antunes(Instituto Português de Oncologia Francisco Gentil), Filipa Quintela Vieira(Instituto Português de Oncologia Francisco Gentil), Jorge Oliveira(Instituto Português de Oncologia Francisco Gentil), Ana Teresa Martins(Instituto Português de Oncologia Francisco Gentil), Inês Graça(Polytechnic Institute of Porto)
Urologic Oncology Seminars and Original Investigations
November 23, 2017
Cited by 52
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112